Skip to content

CONMED CNMD Change in Inventories

Change in Inventories at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$431M+195%
Stryker logo
StrykerSYK
$127M+36.6%
Boston Scientific logo
Boston ScientificBSX
$177M+62.4%
Vericel logo
VericelVCEL
$964K+461%
OSI Systems logo
OSI SystemsOSIS
$47.41M-12.9%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$20.9M+597%

Other financials

Income statement

See full
Revenue$317.0M-1.3%
Gross profit$183.4M+3.2%
Operating income$25.4M+59.3%
Net income$13.8M+129%
EPS (diluted)$0.45+137%

Balance sheet

See full
Cash & equivalents$35.0M-1.3%
Total debt$862.6M-3.6%
Total equity$1.0B+4.1%
Total assets$2.3B+0.8%

Cash flow

See full
Operating cash flow$13.5M-67.6%
CapEx$2.9M-23.5%
Free cash flow$10.6M-72.0%

Valuation

See full
Market cap$1.04B-35.6%
Enterprise value$1.87B-24.5%
P/E19×+5.4×
P/S0.8×-0.5×

Profitability

See full
Gross margin55.2%-1.0pp
Operating margin8.2%-5.6pp
Net margin4%-5.0pp
FCF margin9%-3.5pp

Returns & leverage

See full
Return on equity5.5%-7.5pp
Debt / equity0.8×-0.1×
Current ratio2.3×0.0×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: CONMED’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about CONMED's change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CONMED's change in inventories?
CONMED (CNMD) reported change in inventories of $12.27M in Q1 2026.
How has CONMED's change in inventories changed year-over-year?
CONMED's change in inventories increased by 64.1% year-over-year, from $7.48M to $12.27M.
What is the long-term trend for CONMED's change in inventories?
Over 3 years (2021 to 2024), CONMED's change in inventories has grown at a -5.8% compound annual growth rate (CAGR), from $37.81M to $31.63M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.